Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

NEO
NeoGenomics, Inc.
stock NASDAQ

At Close
Jul 10, 2025 3:59:57 PM EDT
7.49USD-0.598%(-0.04)1,112,296
7.48Bid   7.49Ask   0.01Spread
Pre-market
Jul 10, 2025 8:39:30 AM EDT
7.70USD+2.258%(+0.17)750
After-hours
Jul 10, 2025 4:55:30 PM EDT
7.63USD+1.937%(+0.14)27,511
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
07:06AM EST  NeoGenomics First To Partner With Biomarker Collaborative And Deliver Patient Resources Along With Oncology Testing Results   Benzinga
Jan 12, 2022
09:07AM EST  Where NeoGenomics Stands With Analysts   Benzinga
04:37AM EST  SVB Leerink Maintains Outperform on NeoGenomics, Lowers Price Target to $45   Benzinga
Jan 11, 2022
07:03AM EST  NeoGenomics Subsidiary Inivata Announces RaDaR Assay Receives CE Mark And Is Submitted For US Reimbursement via MolDX Program   Benzinga
Jan 10, 2022
11:55AM EST  New Developments in Fight Against Blood Cancers, in Leadup to US$17.1 Billion   PR Newswire
Dec 16, 2021
10:14AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021   Benzinga
08:07AM EST  Cowen & Co. Initiates Coverage On NeoGenomics with Outperform Rating, Announces Price Target of $42   Benzinga
Dec 10, 2021
07:06AM EST  NeoGenomics Reports Will Leverage Thermo Fisher's Ion Torrent Genexus System In Upcoming Phase 1 Study For Myeloid Cancers   Benzinga
Dec 7, 2021
11:11AM EST  Analyst Ratings For NeoGenomics   Benzinga
06:15AM EST  Needham Maintains Buy on NeoGenomics, Lowers Price Target to $41   Benzinga
Nov 30, 2021
05:00AM EST  Genetron Holdings Limited (Genetron Health or the Company, NASDAQ: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today reported its unaudited preliminary financial results for the third quarter ended September30, 2021.   GlobeNewswire Inc
Nov 8, 2021
11:36AM EST  Genetron Early Monday Reported Entered Strategic Partnership With NeoGenomics To Drive Global Oncology Drug Research, Development   Benzinga
05:00AM EST  Genetron Health Establishes Strategic Partnership with NeoGenomics   GlobeNewswire Inc
Nov 5, 2021
12:13PM EDT  Where NeoGenomics Stands With Analysts   Benzinga
09:51AM EDT  Stephens & Co. Maintains Overweight on NeoGenomics, Lowers Price Target to $53   Benzinga
09:36AM EDT  Needham Maintains Buy on NeoGenomics, Lowers Price Target to $48   Benzinga
09:36AM EDT  SVB Leerink Maintains Outperform on NeoGenomics, Lowers Price Target to $60   Benzinga
Nov 4, 2021
08:19AM EDT  The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO   Benzinga
08:14AM EDT  NeoGenomics Q3 EPS $(0.08) Beats $(0.09) Estimate, Sales $121.34M Miss $125.05M Estimate   Benzinga
08:09AM EDT  Recap: NeoGenomics Q3 Earnings   Benzinga
05:00AM EDT  Earnings Scheduled For November 4, 2021   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 14, 2021
11:18AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2021   Benzinga
07:06AM EDT  Raymond James Upgrades NeoGenomics to Outperform   Benzinga
Oct 4, 2021
12:08PM EDT  Guardant Health Will Not Go With NeoGenomics Deal: Bloomberg   Benzinga
05:02AM EDT  Bloomberg Reported Sunday Guardant Health Decided Against Buying NeoGenomics   Benzinga
Sep 9, 2021
07:07AM EDT  NeoGenomics' Liquid Biopsy Subsidiary Inivata And Collaborators To Present Data That Further Validate The Application Of Its RaDaR(TM) MRD And InVisionFirst(R)-Lung Assays At The ESMO Congress 2021   Benzinga
Aug 12, 2021
04:14AM EDT  Earnings Scheduled For August 12, 2021   Benzinga
Aug 9, 2021
10:55AM EDT  Morgan Stanley Maintains Overweight on NeoGenomics, Lowers Price Target to $58   Benzinga
Aug 6, 2021
10:53AM EDT  NeoGenomics Q2 Earnings Helped By Higher Test Volume; Backs FY21 Guidance   Benzinga
07:51AM EDT  Recap: NeoGenomics Q2 Earnings   Benzinga
07:05AM EDT  NeoGenomics Reaffirms FY21 Sales Guidance Of $490M-$510M vs $500.22M Est.   Benzinga
07:04AM EDT  NeoGenomics Q2 Adj. EPS $(0.01) Beats $(0.06) Estimate, Sales $122.00M Beat $118.16M Estimate   Benzinga
04:22AM EDT  Earnings Scheduled For August 6, 2021   Benzinga
Aug 5, 2021
11:10AM EDT  Earnings Preview: NeoGenomics   Benzinga
11:07AM EDT  NeoGenomics's Earnings: A Preview   Benzinga
Jul 13, 2021
10:55AM EDT  UPDATE: Needham On NeoGenomics Buy Reiteration: Recent Acquisition Of Inivata For $390M Drives Development Of Blood-Based Minimal Residual Disease Test While Synergies Work To Bolster Co.'s Comprehensive Test Menu, According To Firm   Benzinga
10:51AM EDT  Needham Reiterates Buy Rating On NeoGenomics With $55 Price Target   Benzinga
Jul 7, 2021
06:03AM EDT  Energy Fuels And Neo Performance Materials Announce Launch Of Commercial Shipments Of Rare Earth Product To Europe   RTTNews
06:01AM EDT  of Commercial Shipments of Rare Earth Product to Europe in Emerging U.S.-Based Rare Earth Supply Chain   PR Newswire
Jun 3, 2021
10:09AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2021   Benzinga
06:36AM EDT  Goldman Sachs Initiates Coverage On NeoGenomics with Buy Rating, Announces Price Target of $55   Benzinga
May 13, 2021
04:15AM EDT  Earnings Scheduled For May 13, 2021   Benzinga
May 5, 2021
08:38AM EDT  NeoGenomics Exercises Option To Acquire Remaining Stake In Inivata For $390M   Benzinga
08:01AM EDT  Recap: NeoGenomics Q1 Earnings   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues   Benzinga
07:13AM EDT  NeoGenomics To Acquire Invata; Will Purchase Remaining Equity Interest For $390M   Benzinga
07:05AM EDT  NeoGenomics Sees $490M-$510M vs $498.21M Est.   Benzinga
07:02AM EDT  NeoGenomics Q1 Adj. EPS $(0.04) Misses $0.01 Estimate, Sales $116.00M Beat $112.41M Estimate   Benzinga
04:16AM EDT  Earnings Scheduled For May 5, 2021   Benzinga
Apr 7, 2021
08:01AM EDT  IIROC Trade Resumption - NEO   PR Newswire
Apr 6, 2021
03:31PM EDT  IIROC Trading Halt - NEO   PR Newswire
Mar 24, 2021
08:59AM EDT  The Daily Biotech Pulse: Dynavax-Clover Start Phase 2/3 Vaccine Study. BrainStorm Reports Positive MS Readout, NeoGenomics Goes Shopping   Benzinga
07:05AM EDT  NeoGenomics To Acquire Trapelo Health For $65M, Including $35M Cash On Hand And $30M In Cash   Benzinga
Mar 16, 2021
07:10AM EDT  Elevation Oncology, NeoGenomics Collaborate To Expand Genomic Testing Tumors In Support Of Phase 2 CRESTONE Study   RTTNews
07:04AM EDT  NeoGenomics And Elevation Oncology Announce Clinical Trial Matching Collaboration To Expand Genomic Testing For NRG1 Fusions Across Solid Tumors In Support Of Phase 2 CRESTONE Study   Benzinga
07:02AM EDT  Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study   PR Newswire
Feb 25, 2021
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 25, 2021   Benzinga
09:10AM EST  Morgan Stanley Maintains Overweight on NeoGenomics, Raises Price Target to $64   Benzinga
07:28AM EST  Needham Assumes NeoGenomics at Buy, Announces Price Target of $65   Benzinga
07:05AM EST  Raymond James Downgrades NeoGenomics to Market Perform   Benzinga
Feb 24, 2021
07:49AM EST  Recap: NeoGenomics Q4 Earnings   Benzinga
07:30AM EST  The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO   Benzinga
07:06AM EST  NeoGenomics Q4 Adj. EPS $0.14 Beats $0.06 Estimate, Sales $126.00M Beat $123.48M Estimate   Benzinga
03:35AM EST  Earnings Scheduled For February 24, 2021   Benzinga
Feb 17, 2021
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Feb 4, 2021
07:15AM EST  Parexel, NeoGenomics Report Strategic Collaboration In Precision Medicine To Improve Study Designs, Accelerate Patient Matching In Oncology Clinical Trials   Benzinga
07:00AM EST  Parexel and NeoGenomics Announce Strategic Collaboration in   GlobeNewswire Inc
Feb 2, 2021
08:03AM EST  NeoGenomics and Tempus Join the Access to Comprehensive Genomic Profiling   PR Newswire
Jan 28, 2021
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2021   Benzinga
07:11AM EST  Truist Securities Initiates Coverage On NeoGenomics with Buy Rating, Announces Price Target of $65   Benzinga
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
08:18AM EST  IIROC Trade Resumption - NEO   PR Newswire
Jan 25, 2021
03:49PM EST  IIROC Trading Halt - NEO   PR Newswire
Jan 8, 2021
04:59AM EST  SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $60   Benzinga
Jan 6, 2021
07:31AM EST  The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping   Benzinga
06:04AM EST  A Peek Into The Markets: US Stock Futures Mixed Ahead Of Results From Georgia Senate Runoff   Benzinga
Jan 5, 2021
04:08PM EST  NeoGeonmics Announces $200M Proposed Offering Of Common Stock   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Dec 17, 2020
08:10AM EST  The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut   Benzinga
Dec 15, 2020
07:52AM EST  The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding   Benzinga
Dec 11, 2020
09:03AM EST  BTIG Initiates Coverage On NeoGenomics with Buy Rating, Announces Price Target of $60   Benzinga
Dec 8, 2020
08:04AM EST  The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings   Benzinga
Dec 4, 2020
08:04AM EST  The Daily Biotech Pulse: BioCryst's Heredity Angioedema Treatment Clears FDA, Sutro Biopharma Readout, 2 IPOs   Benzinga
Dec 1, 2020
08:08AM EST  The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit   Benzinga
Nov 25, 2020
07:35AM EST  The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback   Benzinga
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 20, 2020
08:08AM EST  10 Biggest Price Target Changes For Friday   Benzinga
06:20AM EST  SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $50   Benzinga
Nov 19, 2020
08:17AM EST  The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 13, 2020
12:08PM EST  OptionsMonster Co-Founder Jon Najarian On CNBC: I'm Not Quite Brave Enough For Marriott, But If You Want Alpha, Look For Value Stocks, Chinese EVs, I've Bought, Li, NIO, XPEV   Benzinga
Oct 28, 2020
08:33AM EDT  Raymond James Maintains Outperform on NeoGenomics, Raises Price Target to $48   Benzinga
07:37AM EDT  Benchmark Maintains Buy on NeoGenomics, Raises Price Target to $48   Benzinga
06:46AM EDT  Needham Maintains Buy on NeoGenomics, Raises Price Target to $46   Benzinga
05:05AM EDT  SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $47   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
07:43AM EDT  NeoGenomics Q3 EPS $0.06 Beats $0.04 Estimate, Sales $125.44M Miss $126.23M Estimate   Benzinga
07:38AM EDT  Recap: NeoGenomics Q3 Earnings   Benzinga
04:18AM EDT  Earnings Scheduled For October 27, 2020   Benzinga
Sep 9, 2020
06:12AM EDT  Morgan Stanley Initiates Coverage On NeoGenomics with Overweight Rating, Announces Price Target of $46   Benzinga
Aug 28, 2020
10:16AM EDT  Benzinga's Top Upgrades, Downgrades For August 28, 2020   Benzinga
07:11AM EDT  Guggenheim Initiates Coverage On NeoGenomics with Buy Rating, Announces Price Target of $46   Benzinga
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
Jul 29, 2020
09:56AM EDT  Raymond James Maintains Outperform on NeoGenomics, Raises Price Target to $40   Benzinga
07:24AM EDT  Benchmark Maintains Buy on NeoGenomics, Raises Price Target to $40   Benzinga
06:56AM EDT  Needham Maintains Buy on NeoGenomics, Raises Price Target to $39   Benzinga
Jul 28, 2020
10:34AM EDT  Recap: NeoGenomics Q2 Earnings   Benzinga
07:19AM EDT  NeoGenomics Q2 EPS $(0.04) Beats $(0.10) Estimate, Sales $86.98M Beat $86.12M Estimate   Benzinga
04:05AM EDT  Earnings Scheduled For July 28, 2020   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC